Effect of known pathological risk factors on the incidence of metastatic lymph nodes and survival in early-stage vulvar cancer: SEER analysis

被引:0
作者
Nahshon, Chen [1 ,2 ,5 ]
Leitao Jr, Mario M. [3 ,4 ]
Lavie, Ofer [1 ,2 ]
Segev, Yakir [1 ,2 ]
机构
[1] Carmel Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY USA
[4] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY USA
[5] Carmel Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 7 Michal St, IL-3436212 Haifa, Israel
基金
美国国家卫生研究院;
关键词
early stage; lymph nodes; metastases; pathological risk factors; survival; vulvar cancer; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; GROINSS-V; LYMPHADENECTOMY; SIZE;
D O I
10.1002/ijgo.15093
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The current study was performed to evaluate the incidence of positive lymph nodes (LNs) in relation to known pathological risk factors, specifically among patients with apparent low-grade, small tumors.Methods: We used the Surveillance, Epidemiology, and End Results (SEER) database to retrospectively identify patients with vulvar squamous cell carcinoma (SCC) diagnosed between January 1, 2000, and December 31, 2019, with known tumor size and regional LN examined. A comparison between patients who had positive and negative LNs was conducted to identify risk factors for LN metastases in relation to survival. Subgroup analysis was conducted in patients with diagnosed grade 1 vulvar SCC and tumor size up to 2 cm according to the status of LNs.Results: Multivariate analysis found that both grade of disease and tumor size were significant factors in predicting LN status. Among patients with low-grade small tumors up to 2 cm, the odds ratio for positive LNs was 2.5 for those with tumor size larger than 1 cm. In a multivariate survival analysis, older age, larger tumor size, and positive LNs were independently associated with decreased survival.Conclusions: The current study confirms that among small tumors, those larger than 1 cm have a significantly increased risk for positive nodes compared with those smaller than 1 cm, and, among this specific group, patients with positive nodes have decreased survival. Future studies are needed to answer the question of whether, in the era of the sentinel node procedure, it is safe to omit LN evaluation altogether.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 23 条
  • [1] An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: Is tumor size significance being underrated?
    Aragona, Alejandro M.
    Cuneo, Nicasio A.
    Soderini, Alejandro H.
    Alcoba, Elsa B.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 643 - 648
  • [2] A review of prognostic factors in squamous cell carcinoma of the vulva: Evidence from the last decade
    Chen, Julia
    Hoang, L. N.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2024, 41 (03) : 140 - 153
  • [3] Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173
    Coleman, Robert L.
    Ali, Shamshad
    Levenback, Charles F.
    Gold, Michael A.
    Fowler, Jeffrey M.
    Judson, Patricia L.
    Bell, Maria C.
    De Geest, Koen
    Spirtos, Nick M.
    Potkul, Ronald K.
    Leitao, Mario M., Jr.
    Bakkum-Gamez, Jamie N.
    Rossi, Emma C.
    Lentz, Samuel S.
    Burke, James J., II
    Van Le, Linda
    Trimble, Cornelia L.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 155 - 159
  • [4] Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel
    Collarino, Angela
    Fuoco, Valentina
    Garganese, Giorgia
    Arias-Bouda, Lenka M. Pereira
    Perotti, Germano
    Manca, Gianpiero
    Vidal-Sicart, Sergi
    Giammarile, Francesco
    de Geus-Oei, Lioe-Fee
    Scambia, Giovanni
    Giordano, Alessandro
    Valdes-Olmos, Renato A.
    Maccauro, Marco
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1261 - 1274
  • [5] The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
    Giannini, Andrea
    D'Oria, Ottavia
    Chiofalo, Benito
    Bruno, Valentina
    Baiocco, Ermelinda
    Mancini, Emanuela
    Mancari, Rosanna
    Vincenzoni, Cristina
    Cutillo, Giuseppe
    Vizza, Enrico
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (03) : 533 - 540
  • [6] Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis
    Grimm, Donata
    Prieske, Katharina
    Mathey, Sabrina
    Kuerti, Sascha
    Burandt, Eike
    Schmalfeldt, Barbara
    Woelber, Linn
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 466 - 473
  • [7] PROGNOSTIC FACTORS FOR GROIN NODE METASTASIS IN SQUAMOUS-CELL CARCINOMA OF THE VULVA (A GYNECOLOGIC-ONCOLOGY-GROUP-STUDY)
    HOMESLEY, HD
    BUNDY, BN
    SEDLIS, A
    YORDAN, E
    BEREK, JS
    JAHSHAN, A
    MORTEL, R
    [J]. GYNECOLOGIC ONCOLOGY, 1993, 49 (03) : 279 - 283
  • [8] Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study
    Klapdor, Ruediger
    Woelber, Linn
    Hanker, Lars
    Schmalfeldt, Barbara
    Canzler, Ulrich
    Fehm, Tanja
    Luyten, Alexander
    Hellriegel, Martin
    Kosse, Jens
    Heiss, Christoph
    Hantschmann, Peer
    Mallmann, Peter
    Tanner, Berno
    Pfisterer, Jacobus
    Jueckstock, Julia
    Hilpert, Felix
    de Gregorio, Nikolaus
    Hillemanns, Peter
    Fuerst, Sophie Teresa
    Mahner, Sven
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 565 - 570
  • [9] Groin Recurrences in Node Negative Vulvar Cancer Patients After Sole Sentinel Lymph Node Dissection
    Klapdor, Ruediger
    Hertel, Hermann
    Soergel, Philipp
    Hillemanns, Peter
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (01) : 166 - 170
  • [10] Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology
    Koh, Wui-Jin
    Greer, Benjamin E.
    Abu-Rustum, Nadeem R.
    Campos, Susana M.
    Cho, Kathleen R.
    Chon, Hye Sook
    Chu, Christina
    Cohn, David
    Crispens, Marta Ann
    Dizon, Don S.
    Dorigo, Oliver
    Eifel, Patricia J.
    Fisher, Christine M.
    Frederick, Peter
    Gaffney, David K.
    Han, Ernest
    Higgins, Susan
    Huh, Warner K.
    Lurain, John R., III
    Mariani, Andrea
    Mutch, David
    Nagel, Christa
    Nekhlyudov, Larissa
    Fader, Amanda Nickles
    Remmenga, Steven W.
    Reynolds, R. Kevin
    Tillmanns, Todd
    Ueda, Stefanie
    Valea, Fidel A.
    Wyse, Emily
    Yashar, Catheryn M.
    McMillian, Nicole
    Scavone, Jillian
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01): : 92 - 120